The disorders in pituitary ACTH release and adrenocortical cortisol secretion characterize Cushing's syndrome. Increased or high normal plasma ACTH concentrations, impaired suppression of ACTH and cortisol release following relatively low does dexamethasone administration, and hyperresponsiveness to metyrapone and lysine-8-vasopressin (LVP) are characteristic findings in patients with pituitary dependent Cushing's syndrome (Cushing's disease or adrenal hyperplasia). While, in patients with adrenal tumors (adrenal adenoma and adrenal carcinoma), undetectable level of plasma. ACTH, no suppression of cortisol release following high dose dexamethasone administration and no response of ACTH and cortisol to metyrapone and LVP are characteristic.
In recent years, the development of the sensitive and reliable radioimmunoassay for several pituitary hormones, in addition to the synthesis of hypothalamic releasing hormones has permitted the evaluation of the pituitary reserves for these hormones. To assess the pituitary reserves of thesehormones in patients with Cushing's syndrome, we examined the responses of plasma ACTH, GH, LH, FSH, TSH and prolactin to hydrocortisone, LVP, insulin-induced hypoglycemia, luteinizing hormone-releasing hormone (LH-RH) and thyrotropin releasing hormone (TRH). A comparison was made between patients with Cushing's disease and adrenal tumors. Another comparison was also made between the responses before and after treatment.
Patients and Methods
Eighteen patients with Cushing's syndrome were investigated. Fourteen patients had Cushing's disease, 3 had adrenocortical adenoma and one had adrenal carcinoma.
The pituitary-adrenal functions in these patients are listed on 
Results
Pituitary ACTH reserve As shown in Table 1 , patients with Cushing's disease had high resting levels of plasma ACTH, while all patients with adrenal tumors had undetectable levels. Normal or increased urinary 17-KGS responses to oral administration of metyrapone and sufficient plasma ACTH response to LVP were observed in Cushing's disease, while no response to metyrapone and LVP was observed in adrenal adenoma (Table 1 , Fig. 1 .). After treatment, more elevation of resting ACTH levels was found in totally adrenalectomized Cushing's disease (360.1 infusion of 150mg of hydrocartison over 2 hours produced no fall in plasma ACTH until 180min in a patient with Cushing's disease treated with pituitary irradiation, while the decrease of plasma ACTH was found by 60min in 3 totally adrenalectomized Cushing's disease. Significant decrease in plasma ACTH was not found by 30min in these patients, while it was already found by 30min in 3 patients with Addison's disease whose basal ACTH levels were also high ( Fig. 2) . Fig. 5 ).
Discussion
The basal levels of plasma ACTH were increased or high normal in our patients with Cushing's disease and undetectable in patients with adrenal tumors. Sufficient pituitary response of ACTH to LVP in Cushing's disease and no response of ACTH to LVP in adrenal tumors were demonstrated. These findings were already reported in the previous literature (Ney et al., 1963; Graber et al., 1965; Demura et al., 1966; Demura et al., 1972; Croughs et al., 1973) In patients with totally adrenalectomized Cushing's disease, the infusion of 150mg hydrocortisone did not suppress plasma ACTH by 30 min, while the suppression was already observed by 30min in 3 patients with Addison's disease whose basal ACTH levels were also high. This finding suggests the abnormality in the feedback mechanism of ACTH secretion continuing after the clinically effective treatment. One Cushing's disease treated with pituitary irradiation showed no suppression until 180 min. This impaired suppression was due to the ineffective treatment of pituitary irradiation.
The lack of normal growth hormone responsiveness to insulin induced hypoglycemia in our patients is in agreement with that reported in the literature (Frantz et al., 1964; Hartog et al., 1964; James et al. , 1968; Strauch et al., 1969; Morrow et al., 1969; Werder et al. 1971; Krieger and Glick, 1972; Demura et al., 1972; Werder et al., 1971) reported that the patients with hyper-adrenocorticism showed virtually no growth hormone elevation in response to the stress induced by hypoglycemia, behaving similar to dexamethoasone suppressed subjects. Stiel et al. (1970) reported that normal subjects treated for 2 weeks with predonisolone in doses of 15 mg per day showed no significant diminution in their spontaneous plasma GH peaks and postulated that the chronicity, the constancy and the severity of glucocorticoid excess might all be the factors in abolishing the plasma GH peaks in Cushing's syndrome. Morrow et al. (1969) and Demura et al. (1972) observed the abnormal responses to stimuli tended to become normal with improvement after treatment. These findings would imply the abnormal responses of GH, being due to hypercortisolemia. While, James et al. (1968) and Krieger and Glick (1972) reported the lack of normal GH response to insulininduced hypoglycemia in the subjects with Cushing's disease either active or in remission, indicating that the abnormal responses observed were not secondary to hypercortisolemia alone, and postulated these abnormalities presumes to act via central nervous system releasing mechanism of GH as well as ACTH. In our patients, impaired responsiveness of plasma GH was also found after treatment, but sufficient response was also observed in a totally adrenalectomized patient with Cushing's disease. According to our results and the results in the literature, the hypercortisolemia may play a primary role in abolishing normal response, even though patients with Cushing's disease may also have altered central mechanism regulating GH secretion.
Patient SK and SF showed excessive LH responses. Their menstruations were irregular since their menarche and they were suspected to have primary ovarial disfunction. Except for these cases and one child case (MM), the mean resting levels of plasma LH before and after treatment were 13. LH and FSH reserves were preserved in more than half of the patients examined.
The pituitary prolactin reserve were normal in most patients. But the possibility that PIF might be suppressed by cortisol was also proposed. Hypercortisolemia is considered to be responsible for the impairements of these pituitary reserves observed in some patients. It may be a danger to discuss the difference of the suppressibility of these pituitary hormones from the above results, since the strength of stimuli used in this study are not identical to release each hormone and the places where these stimuli act on are not the same. However, if this is judged simply from our observation, the order of suppressibility of these pituitary hormones by cortisol might be ACTH, GH, TSH, LH and FSH, and then prolactin.
